<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Borens O</dc:creator>
  <dc:creator>Corvec S</dc:creator>
  <dc:creator>Trampuz A</dc:creator>
  <dc:date>2012</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Advances in implant design, surgical technique, peri-operative antimicrobial prophylaxis and laminar airflow operating room environment have made total joint arthroplasty one of the most successful surgical procedures of all times. Orthopaedic implants, however, remain prone to microbial contamination resulting in persistent risk of implant-associated infection. Treatment of infections associated with orthopaedic devices usually requires appropriate surgical intervention combined with a prolonged antimicrobial therapy. The choice of the best possible treatment regimen depends on duration and pathogenesis of infection, stability of the implant, antimicrobial susceptibility of the pathogen and condition of the surrounding soft tissue. In addition towell known diagnostic procedures new promising tools for rapid and correct microbial diagnosis are being developed as correct diagnosis of the responsible micro-organism and this is paramount for successful treatment of prosthetic joint infection.</dc:description>
  <dc:identifier>https://sonar.ch/global/documents/43124</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.5301/HIP.2012.9565</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/pmid/22956373</dc:relation>
  <dc:source>Hip international : the journal of clinical and experimental research on hip pathology and therapy. - 2012</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Anti-Bacterial Agents</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Bacteria</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Bacterial Infections</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Biofilms</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Humans</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">In Situ Hybridization, Fluorescence</dc:subject>
  <dc:subject xmlns:ns7="xml" ns7:lang="en">Joint Prosthesis</dc:subject>
  <dc:subject xmlns:ns8="xml" ns8:lang="en">Joints</dc:subject>
  <dc:subject xmlns:ns9="xml" ns9:lang="en">Leukocytes</dc:subject>
  <dc:subject xmlns:ns10="xml" ns10:lang="en">Prosthesis-Related Infections</dc:subject>
  <dc:subject xmlns:ns11="xml" ns11:lang="en">Reoperation</dc:subject>
  <dc:subject xmlns:ns12="xml" ns12:lang="en">Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization</dc:subject>
  <dc:subject xmlns:ns13="xml" ns13:lang="en">Synovial Fluid</dc:subject>
  <dc:title xmlns:ns14="xml" ns14:lang="en">Diagnosis of periprosthetic joint infections.</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
